
Acemox250 mg
ACME Laboratories Ltd.
Acetazolamide is a carbonic anhydrase inhibitor used as adjunctive (add-on) therapy for several conditions and more.
Acetazolamide is a carbonic anhydrase inhibitor used as adjunctive (add-on) therapy for several conditions, with the strength of evidence varying by indication:
Note: Acetazolamide is always used as an adjunct in epilepsy and edema; it is not intended as sole/first-line therapy for these conditions.
| Type | Adult Dose |
|---|---|
| Chronic open-angle glaucoma | 250 mg to 1 g per day, usually in divided doses; doses above 1 g/day give no additional benefit |
| Secondary glaucoma / preoperative acute angle-closure glaucoma | 250 mg every 4 hours, or 250 mg twice daily short-term; in acute cases, an initial 500 mg dose followed by 125-250 mg every 4 hours |
Total daily dose of 8 to 30 mg/kg in divided doses; optimum range is usually 375-1000 mg daily. When added to existing anticonvulsant therapy, start at 250 mg once daily and titrate as needed.
250-375 mg once daily in the morning (approximately 5 mg/kg); best results are often obtained with intermittent dosing (alternate days, or two days on/one day off) to avoid reduced diuretic response.
500-1000 mg daily in divided doses; the higher dose is preferred for rapid ascent. Start dosing 24-48 hours before ascent and continue for at least 48 hours after arrival at high altitude (or longer if symptoms persist).
Tablets may be taken with or without food; taking with food may reduce stomach upset. Tablets can be crushed and mixed with soft food (e.g., applesauce) or a flavored syrup for patients who have difficulty swallowing. See Renal/Hepatic notes under Precautions and Special Populations.
Side effects of Acetazolamide range from common and generally mild to rare but serious:
Acetazolamide is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.